PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35017453-2	2022	High levels of raltegravir and dolutegravir can potentially cause bilirubin toxicity as they compete for albumin binding and follow the same metabolic pathway through UGT1A1.	Raltegravir Potassium	15-26	albumin	Homo sapiens	105-112	
32661003-6	2020	The unbound raltegravir was described by a one compartment model with a transit compartment with first order absorption, evolving either to bound raltegravir (by a linear binding to albumin), or metabolism to RAL-glucuronide or to a first order elimination, with a circadian rhythm.	Raltegravir Potassium	12-23	albumin	Homo sapiens	182-189